Overall a positive conference call. In my mind the biggest news is that they saw clinical efficacy as compared to placebo when it came to National Early Warning Score (NEWS)2 as well as decreased need for supplemental oxygen.
Would appreciate some clarification:
On previous calls Nader had indicated we would definitely need to do a Phase III for HIV monotherapy and this BLA submission would not cover that. Has this changed?